Bionano Genomics, Inc. (BNGO)
- Previous Close
0.4317 - Open
0.4280 - Bid 0.3079 x 200
- Ask 0.5616 x 200
- Day's Range
0.4229 - 0.4470 - 52 Week Range
0.3100 - 3.0100 - Volume
888,510 - Avg. Volume
1,735,953 - Market Cap (intraday)
37.753M - Beta (5Y Monthly) 2.33
- PE Ratio (TTM)
0.04 - EPS (TTM)
9.8900 - Earnings Date Nov 6, 2024 - Nov 11, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
1.90
Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.
www.bionano.comRecent News: BNGO
View MorePerformance Overview: BNGO
Trailing total returns as of 10/3/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BNGO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BNGO
View MoreValuation Measures
Market Cap
37.73M
Enterprise Value
46.36M
Trailing P/E
0.04
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.43
Price/Book (mrq)
0.47
Enterprise Value/Revenue
1.27
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-32.64%
Return on Equity (ttm)
-138.33%
Revenue (ttm)
36.58M
Net Income Avi to Common (ttm)
-204.1M
Diluted EPS (ttm)
9.8900
Balance Sheet and Cash Flow
Total Cash (mrq)
18.94M
Total Debt/Equity (mrq)
34.32%
Levered Free Cash Flow (ttm)
-55.98M